Compound
acetic acid
Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
Structure
Acetic acid, the two-carbon monocarboxylic acid.
Loading the model…
- Class
- Organic compound
- Formula
- C2H4O2
- Mass
- 60.052 g/mol
- Charge
- 0
- InChIKey
- QTBSBXVTEAMEQO-UHFFFAOYSA-N
- SMILES
- CC(=O)O
- Look it up
- ChEBIPubChemBy InChIKey
Identity from ChEBI, geometry from PubChem. Not evidence.
What the reference databases state
Chemical structure
- (2-hydroxyphenyl)acetic acid has the functional parent acetic acidCompoundChEBI CHEBI:28478Inferred only
- 1-hexadecanoyl-2-acetyl-sn-glycero-3-phosphocholine has the functional parent acetic acidCompoundChEBI CHEBI:75219Inferred only
- 1-O-hexadecyl-2-acetyl-sn-glycerol has the functional parent acetic acidCompoundChEBI CHEBI:75936Inferred only
- 1-octadecanoyl-2-acetyl-sn-glycero-3-phosphocholine has the functional parent acetic acidCompoundChEBI CHEBI:75220Inferred only
- 2-acetyl-sn-glycero-3-phosphocholine has the functional parent acetic acidCompoundChEBI CHEBI:78045Inferred only
- an acetyl ester has the functional parent acetic acidCompoundChEBI CHEBI:47622Inferred only
- CHEBI:15351 has the functional parent acetic acidCompoundChEBI CHEBI:15351Inferred only
- triacetin has the functional parent acetic acidCompoundChEBI CHEBI:9661Inferred only
Statements
1 statement
1 statement · 1 reference database · Subject: acetic acid · Sources: ChEBI
- potassium acetate is converted to acetic acidCompoundChEBI CHEBI:32029Inferred only
On the label
Labelled products
16 products
Source: NIH DSLD · Ingredient: acetic acid · 16 products · Declared amount per serving: 50–750 mg (7 products)
7 labels state an amount9 do not
- 21st CenturyApple Cider Vinegar 2145 mg750 mgper 3 Vegan Capsule(s)DSLD:304092
- BluebonnetApple Cider Vinegarstandardized to 5% acetic acid50 mgper 2 Vegetable Capsule(s)DSLD:314777
- BluebonnetApple Cider Vinegarstandardized to 5% acetic acid50 mgper 2 Capsule(s)DSLD:315775
- BraggApple Cider Vinegar750 mgper 3 Vegan Capsule(s)DSLD:273912
- BraggDaily Balance750 mgper 3 Vegan Capsule(s)DSLD:317737
- BraggInner Glow750 mgper 3 Vegan Capsule(s)DSLD:317738
- BraggTrue Energy750 mgper 3 Vegan Capsule(s)DSLD:317741
- Dr. Ohhira'sProbioticsShort-chain fatty acids and other organic acidsamount not statedper 1 Capsule(s)DSLD:295780
- Dr. Ohhira'sProbiotics Original Formulaamount not statedper 2 Capsule(s)DSLD:37022
- Dr. Ohhira'sProbiotics Original Formulaamount not statedper 1 Capsule(s)DSLD:38666
- Dr. Ohhira'sProbiotics Professional Formulaamount not statedper 1 Capsule(s)DSLD:38622
- Premier Research LabsPremier Probiotic Capsamount not statedper 1 Capsule(s)DSLD:297565
Show the remaining 4
- Premier Research LabsPremier Probiotic Capsamount not statedper 1 Capsule(s)DSLD:297566
- Quantum Nutrition LabsQuantum Probiotic Supportshort-chain fatty acids and other organic acidsamount not statedper 2 Softgel(s)DSLD:329097
- Systemic Formulas Bio ChallengeLGLUT Leaky Gut Masteryapple cider vinegaramount not statedper 1 Capsule(s)DSLD:22181
- TriquetraFlora Biomeamount not statedper 15 mLDSLD:276287
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- acetic acid
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
205 trials
205 registered trials without posted results · Overdue (FDAAA 801): 113 · Showing 120 of 205
113 past the window7 within it, or no actual date
- NCT04120246suspended— Study placed on hold.expected 2028-02-01industry
- NCT07414875completed2026-05-06a university or hospital
- NCT07710898completed2026-04-12a university or hospital
- NCT07043478completed2026-03-22industry
- NCT06438562completed2025-11-27a university or hospital
- NCT03107780terminated— Drug supply issues2025-08-15NIHpast the reporting window
- NCT06412653completed2025-08-04a university or hospitalpast the reporting window
- NCT04054713suspended— not enough patients enrolledexpected 2025-05-01a government body
- NCT05617872completed2025-05-01a university or hospitalpast the reporting window
- NCT04450693completed2025-03-24industrypast the reporting window
- NCT07501520completed2025-03-10a university or hospitalpast the reporting window
- NCT06437405completed2025-02-15a university or hospitalpast the reporting window
Show the remaining 193
- NCT06736366completed2024-12-16a university or hospitalpast the reporting window
- NCT06319443completed2024-12-15a university or hospitalpast the reporting window
- NCT06834711completed2024-12-12a university or hospitalpast the reporting window
- NCT05870787completed2024-12-06a university or hospitalpast the reporting window
- NCT06166420completed2024-08-31a university or hospitalpast the reporting window
- NCT06356480completed2024-04-30a university or hospitalpast the reporting window
- NCT06481254completed2024-02-13a university or hospitalpast the reporting window
- NCT04176120completed2024-01-25industrypast the reporting window
- NCT05234112completed2023-12-30a university or hospitalpast the reporting window
- NCT06135116completed2023-12-23a university or hospitalpast the reporting window
- NCT05970536completed2023-12-01a university or hospitalpast the reporting window
- NCT05503368suspended— lack of availability of the needed kitsexpected 2023-11a university or hospital
- NCT05682261completed2023-10-17a government bodypast the reporting window
- NCT04113616terminated— In September 2023, the study was terminated because of a Sponsor decision, unrelated to safety concerns.2023-09-27industrypast the reporting window
- NCT05698381completed2023-08-15a university or hospitalpast the reporting window
- NCT02689024terminated— recruitment too slow; intervention was standard care in patients who were not included; acute care pathways changed due to policy regarding hip fracture patients2023-07-19a university or hospitalpast the reporting window
- NCT06612164completed2023-06-30a university or hospitalpast the reporting window
- NCT05778227completed2023-05-15a university or hospitalpast the reporting window
- NCT05759442completed2023-04-01a university or hospitalpast the reporting window
- NCT05476952completed2023-03-18a university or hospitalpast the reporting window
- NCT04444765completed2022-12-31a university or hospitalpast the reporting window
- NCT05100264completed2022-12-29a university or hospitalpast the reporting window
- NCT06748313completed2022-10-10a university or hospitalpast the reporting window
- NCT05523115completed2022-10-01industrypast the reporting window
- NCT05027867terminated— Unanticipated and extremely high screen failure rate. There was no evidence of safety concerns in the study.2022-08-26industrypast the reporting window
- NCT05710094completed2022-08-19industrypast the reporting window
- NCT03532555terminated— Slow enrollment2022-05-25a university or hospitalpast the reporting window
- NCT05272228completed2022-05-15a university or hospitalpast the reporting window
- NCT05418439completed2022-05-01industrypast the reporting window
- NCT04621149terminated— Unable to recruit participants due to decline in COVID-19.2022-03-31a university or hospitalpast the reporting window
- NCT07190911completed2022-03-09a university or hospitalpast the reporting window
- NCT06055101completed2022-03-06a university or hospitalpast the reporting window
- NCT05778383completed2022-02-23a university or hospitalpast the reporting window
- NCT03117816completed2022-01-26a university or hospitalpast the reporting window
- NCT07365956completed2022-01-01a university or hospitalpast the reporting window
- NCT03332355terminated— Business Reasons2021-12-31industrypast the reporting window
- NCT04706520terminated— study sponsor ended due to recruitment issues2021-11-04a university or hospitalpast the reporting window
- NCT04911075completed2021-10-25a university or hospitalpast the reporting window
- NCT02335372completed2021-10-07a university or hospitalpast the reporting window
- NCT06005519completed2021-08-30a university or hospitalpast the reporting window
- NCT04000503completed2021-07-31a university or hospitalpast the reporting window
- NCT05038059completed2021-06-03a university or hospitalpast the reporting window
- NCT04415840completed2021-05-25a university or hospitalpast the reporting window
- NCT02420665completed2021-05-14a university or hospitalpast the reporting window
- NCT05073211completed2021-04-01a university or hospitalpast the reporting window
- NCT04083053completed2021-01-15a university or hospitalpast the reporting window
- NCT04365270completed2021-01-05a university or hospitalpast the reporting window
- NCT04189874completed2020-12-31a university or hospitalpast the reporting window
- NCT05211271completed2020-12-31a university or hospitalpast the reporting window
- NCT04319692completed2020-12-30a university or hospitalpast the reporting window
- NCT04706806completed2020-11-17a university or hospitalpast the reporting window
- NCT05445362completed2020-08-30a university or hospitalpast the reporting window
- NCT03111810completed2020-08-01a university or hospitalpast the reporting window
- NCT04527263completed2020-07-01a university or hospitalpast the reporting window
- NCT04001855terminated— Investigator left university2020-05-31a university or hospitalpast the reporting window
- NCT04657757completed2020-03-31a university or hospitalpast the reporting window
- NCT03619161completed2019-12-18a university or hospitalpast the reporting window
- NCT03775590terminated— Study closed due to lack of enrollment.2019-09-15a university or hospitalpast the reporting window
- NCT04120259completed2019-08-26a university or hospitalpast the reporting window
- NCT04245488completed2019-08-20a university or hospitalpast the reporting window
- NCT04401670completed2019-08-01a university or hospitalpast the reporting window
- NCT04173520completed2019-08a university or hospitalpast the reporting window
- NCT03464552completed2019-06-30a university or hospitalpast the reporting window
- NCT04070391completed2019-06-01a university or hospitalpast the reporting window
- NCT03313297completed2019-02-27a university or hospitalpast the reporting window
- NCT02110355completed2018-12-27industrypast the reporting window
- NCT01360541completed2018-12-14a university or hospitalpast the reporting window
- NCT02697344completed2018-10-26a university or hospitalpast the reporting window
- NCT03204955completed2018-09-30a university or hospitalpast the reporting window
- NCT03577834completed2018-08-15a university or hospitalpast the reporting window
- NCT02560610completed2018-08-02industrypast the reporting window
- NCT03126123completed2018-07-31a university or hospitalpast the reporting window
- NCT03369002completed2018-05-15industrypast the reporting window
- NCT03031093completed2018-04-03a university or hospitalpast the reporting window
- NCT02582788terminated2018-04a university or hospitalpast the reporting window
- NCT03853200completed2018-02-01a university or hospitalpast the reporting window
- NCT02192346completed2017-12-11a university or hospitalpast the reporting window
- NCT02868151completed2017-12a university or hospitalpast the reporting window
- NCT03593135completed2017-11-14a university or hospitalpast the reporting window
- NCT02800772completed2017-08a university or hospitalpast the reporting window
- NCT02760095completed2017-06a university or hospitalpast the reporting window
- NCT02016729completed2017-04-19industrypast the reporting window
- NCT01723020completed2017-03-15industrypast the reporting window
- NCT03200197completed2017-03a university or hospitalpast the reporting window
- NCT02873741completed2017-02-27a university or hospitalpast the reporting window
- NCT02407392completed2017-01-31a government bodypast the reporting window
- NCT02707549completed2016-12a university or hospitalpast the reporting window
- NCT02714127completed2016-12a university or hospitalpast the reporting window
- NCT02996513completed2016-12a university or hospitalpast the reporting window
- NCT02945111completed2016-10a university or hospitalpast the reporting window
- NCT01727908terminated— guideline developed2016-09a university or hospitalpast the reporting window
- NCT01964118completed2016-09a university or hospitalpast the reporting window
- NCT02494310completed2016-08-31a university or hospitalpast the reporting window
- NCT02863016completed2016-08a university or hospitalpast the reporting window
- NCT02338141terminated— Funding unavailable to perform study.2016-02a university or hospitalpast the reporting window
- NCT02472535completed2016-02industrypast the reporting window
- NCT02620956completed2015-12a university or hospitalpast the reporting window
- NCT02189083completed2015-11a university or hospitalpast the reporting window
- NCT02253719completed2015-09a university or hospitalpast the reporting window
- NCT02693379completed2015-09a university or hospitalpast the reporting window
- NCT02363244completed2015-08a government bodypast the reporting window
- NCT05008250completed2015-08a university or hospitalpast the reporting window
- NCT02688816completed2015-06a university or hospitalpast the reporting window
- NCT02341521completed2015-05industrypast the reporting window
- NCT03212729completed2015-05a university or hospitalpast the reporting window
- NCT02390180completed2015-03a university or hospitalpast the reporting window
- NCT05095493completed2014-10-31a university or hospitalpast the reporting window
- NCT02230228completed2014-09industrypast the reporting window
Papers screened
616 papers
- Compound
- acetic acid
- Screened
- 616
- Admitted
- 0
- Discarded
- 355
- Not read
- 261
- Showing
- 200 of 616
Discarded: the wrong intervention279 papers
- PMID:15170675cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:15343217cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:15798842cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:16291985cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:17638204cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:21387289cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:22622343cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:22960894cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:23326441cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:23842133cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:24331748cited by PMID:25849627; not about the subject it would be filed under2026-10-18
- PMID:24433568cited by PMID:25849627; not about the subject it would be filed under2026-10-18
and 267 more.
Discarded: another reason, stated per paper26 papers
and 26 more.
Discarded: not retrievable20 papers
- PMID:19805020no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-18
- PMID:24716265no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-18
- PMID:14907713no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:24422no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:4973948no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:7557106no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:7916405no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:8295932no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
- PMID:8299918no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-16
and 11 more.
Discarded: an endpoint this vocabulary does not hold15 papers
- PMID:24507431claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)2026-09-29
and 14 more.
Discarded: no extractable result9 papers
and 9 more.
Discarded: no comparator6 papers
and 6 more.
Not read yet261 papers
- PMID:108619942026-10-25
- PMID:429070952026-10-23
- PMID:102223832026-10-07
- PMID:162777722026-10-07
- PMID:36789502026-10-07
- PMID:60921992026-10-01
- PMID:158889692026-10-01
- PMID:161382332026-10-01
- PMID:166149572026-10-01
- PMID:169412502026-10-01
- PMID:197743482026-10-01
- PMID:219335272026-10-01
and 249 more.
Measured, not recorded
- Compound
- acetic acid
- Endpoints measured
- 138 endpoints
- Recorded as a finding
- No
Show what was measured
efficacy of hemodialysis in eliminating accumulated 5HT and 5HIAA
no effect
HD did not eliminate accumulated 5HT and 5HIAA effectively.
PMID:11763663 · one of two readings recorded this
efficacy of hemodialysis in eliminating accumulated serotonin and 5HIAA
no effect
HD did not eliminate accumulated 5HT and 5HIAA effectively.
PMID:11763663 · one of two readings recorded this
plasma 5-hydroxyindoleacetic acid (5HIAA) concentration, HPLC with electrochemical detection
increases
In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed.
PMID:11763663 · one of two readings recorded this
plasma 5-hydroxyindoleacetic acid (5HIAA) concentration
increases
In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed.
PMID:11763663 · one of two readings recorded this
plasma and urinary 5-hydroxyindoleacetic acid (5HIAA) concentration, HPLC with electrochemical detection, and platelet/plasma serotonin (5HT)
increases
Not recorded as a finding: subject_absent
In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed.
PMID:11763663 · one of two readings recorded this
platelet serotonin (5HT) content
no effect
In patients with CRI accumulation of 5HT and 5HIAA in plasma with no changes in platelet 5HT content was revealed.
PMID:11763663 · one of two readings recorded this
renal and fractional excretion (FE) of 5HT
decreases
5HT renal and fractional excretion (FE) was markedly decreased in CRI.
PMID:11763663 · one of two readings recorded this
renal excretion of 5HIAA in hemodialysed patients
decreases
Due to the increased filtration load renal excretion of 5HIAA was not altered in CT patients, however it was decreased in HD patients.
PMID:11763663 · one of two readings recorded this
renal fractional excretion of 5HIAA
decreases
In CRI FE-5HIAA decreased.
PMID:11763663 · one of two readings recorded this
renal fractional excretion of serotonin (FE-5HT)
decreases
5HT renal and fractional excretion (FE) was markedly decreased in CRI.
PMID:11763663 · one of two readings recorded this
morning pain
increases, acetic acid/taping group showed significantly greater improvement than dexamethasone/taping
However for morning pain, the acetic acid/taping group showed a significantly greater improvement than the dexamethasone/taping intervention.
PMID:16488901 · one of two readings recorded this
morning stiffness and pain symptoms of plantar fasciitis after acetic acid iontophoresis versus dexamethasone or placebo iontophoresis, combined with LowDye taping
decreases, only acetic acid iontophoresis maintained the treatment effect for stiffness symptoms at 4-week follow-up compared with placebo and dexamethasone, p = 0.031
Not recorded as a finding: this platform holds no node for the endpoint
In contrast, only acetic acid maintained treatment effect for stiffness symptoms compared with placebo (p = 0.031) and dexamethasone.
PMID:16488901 · one of two readings recorded this
morning stiffness symptoms at 4-week follow-up
decreases, acetic acid maintained treatment effect for stiffness vs placebo and dexamethasone, p = 0.031
In contrast, only acetic acid maintained treatment effect for stiffness symptoms compared with placebo (p = 0.031) and dexamethasone.
PMID:16488901 · one of two readings recorded this
percentage of biopsies containing specialized columnar epithelium detected by acetic acid-guided targeted biopsy after magnifying endoscopy versus random four-quadrant biopsy in Barrett's oesophagus
increases, 78% (188/241) vs 57% (159/280)
Not recorded as a finding: the compound was a reagent, not an exposure
Acetic acid-guided biopsies obtained a significantly higher percentage of tissues containing SCE (78%; 188/241) compared to random biopsies (57%; 159/280).
PMID:16813794 · one of two readings recorded this
clinical resolution rate of otitis externa and infected mastoid cavities at 2 and 4 weeks, assessed by otoscopy
38% (12/32) resolution after 4 weeks
Not recorded as a finding: this platform holds no node for the endpoint
Patients on glacial acetic acid had only 38% (12/32) resolution after 4 weeks (P < 0.0005).
PMID:17184455 · one of two readings recorded this
Resolution of active otitis externa and infected mastoid cavity disease, assessed by otoscopy at 2 and 4 weeks
increases
Not recorded as a finding: the intervention held more than the compound
Glacial acetic acid, dexamethasone and neomycin sulphate is significantly more effective in treating otitis externa when compared with glacial acetic acid.
PMID:17184455 · one of two readings recorded this
per-lesion and per-patient sensitivity and positive predictive value of targeted biopsies for high-grade intraepithelial neoplasia/early cancer, comparing computed virtual chromoendoscopy with conventional chromoendoscopy using acetic acid
87% (26/30) for both CAA and CVC
Not recorded as a finding: the compound was a reagent, not an exposure
The sensitivity of targeted biopsies for HGIN/early cancer on a 'per lesion' basis was 87 % (26/30) for both CAA and CVC.
PMID:17611913 · one of two readings recorded this
taxonomic classification and phylogenetic grouping of acetic acid bacteria genera
In the acetic acid bacteria, ten genera are presently recognized and accommodated to the family Acetobacteraceae, the Alphaproteobacteria.
PMID:18199517 · one of two readings recorded this
overall survival and recurrence-free survival after percutaneous acetic acid injection compared with percutaneous ethanol injection or surgery for early hepatocellular carcinoma
no effect, HR 1.47; 95% CI 0.68 to 3.19 overall survival, and HR 1.42; 95% CI 0.68 to 2.94 recurrence-free survival, PEI vs PAI, n = 261
Not recorded as a finding: the comparison was against another active treatment
Overall survival (HR 1.47; 95% confidence interval (CI) 0.68 to 3.19) and recurrence-free survival (HR 1.42; 95% CI 0.68 to 2.94) were not significantly different.
PMID:19588401 · one of two readings recorded this
overall survival and recurrence-free survival
no effect, HR 1.47; 95% CI 0.68-3.19 overall survival; HR 1.42; 95% CI 0.68-2.94 recurrence-free survival, PEI vs PAI, n = 261
Overall survival (HR 1.47; 95% confidence interval (CI) 0.68 to 3.19) and recurrence-free survival (HR 1.42; 95% CI 0.68 to 2.94) were not significantly different.
PMID:19588401 · one of two readings recorded this
overall survival, recurrence, complete tumour necrosis and complications after percutaneous acetic acid injection compared with radiofrequency ablation and percutaneous ethanol injection for hepatocellular carcinoma
no effect, OR 0.55; 95% CI 0.23-1.33; p=0.18 for survival, PAI vs PEI, p = 0.18, n = 1035
Not recorded as a finding: the comparison was against another active treatment
PAI did not differ significantly from PEI for survival (OR 0.55; 95% CI 0.23-1.33; p=0.18), and local recurrence but required less sessions.
PMID:20149473 · one of two readings recorded this
overall survival
no effect, OR 0.55; 95% CI 0.23-1.33; p=0.18, PAI vs PEI, p = 0.18, n = 1035
PAI did not differ significantly from PEI for survival (OR 0.55; 95% CI 0.23-1.33; p=0.18), and local recurrence but required less sessions.
PMID:20149473 · one of two readings recorded this
sensitivity, specificity, positive predictive value and negative predictive value for detecting cervical intraepithelial neoplasia grade 2 or higher
pooled sensitivity 71.8%, specificity 79.4%, PPV 16.7%, NPV 99.0%
Using random effect method, the pooled estimates of sensitivity, specificity, positive predictive value and negative predictive value of VIA-VIAM were 71.8%, 79.4%, 16.7% and 99.0% respectively.
PMID:21294423 · one of two readings recorded this
acetic acid-induced abdominal constrictions (writhing)
Cordymin inhibited the acetic acid-induced abdominal constrictions in mice in a dose-dependent manner.
PMID:22348255 · one of two readings recorded this
cytokine levels (TNF-alpha, IL-1 beta) and total antioxidant status
decreases
Cordymin treatment decreased the levels of tumour necrosis factor alpha, interleukin 1 beta and total antioxidant status.
PMID:22348255 · one of two readings recorded this
acetic acid-induced writhing (abdominal constriction count)
Acetic acid-induced writhing and hot-plate tests were employed to study the analgesic effect of glycoproteins and compared with that of aspirin or morphine.
PMID:23747537 · one of two readings recorded this
colon weight/length
increases, p = 0.001
In AA group, mean colonic weights were significantly (P < 0.001) increased compared to control animals.
PMID:24507431 · one of two readings recorded this
colon weight
increases, p = 0.001
In AA group, mean colonic weights were significantly (P < 0.001) increased compared to control animals.
PMID:24507431 · one of two readings recorded this
colonic adherent mucus content (Alcian blue binding)
decreases, p = 0.01
Mucus content of rats' colon in AA group was significantly (P <0.01) reduced compared to controls.
PMID:24507431 · one of two readings recorded this
colonic histopathology (ulceration, necrosis, inflammation, edema, goblet cell hyperplasia)
increases
In AA group, a diffused active UC was seen along with severe necrosis and inflammation associated with edema, goblet cell hyperplasia
PMID:24507431 · one of two readings recorded this
colonic interleukin-6 concentration, ELISA (pg/mg tissue)
increases, p = 0.05
Not recorded as a finding: interleukin-6 node requires serum or plasma concentration; this value is colon tissue
Colonic levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α were significantly (P < 0.05, P < 0.05 and P < 0.01 respectively) increased in AA administered group compared to control rats.
PMID:24507431 · one of two readings recorded this
colonic malondialdehyde (TBARS) concentration, colon tissue TBARS assay
increases, p = 0.01
Not recorded as a finding: malondialdehyde-circulating requires serum, plasma or whole blood; this value is colon tissue homogenate, a different matrix
The TBARS levels were found significantly (P < 0.01) increased in AA administered group compared to control rats.
PMID:24507431 · one of two readings recorded this
colonic mucus content
decreases, p = 0.01
Mucus content of rats' colon in AA group was significantly (P <0.01) reduced compared to controls.
PMID:24507431 · one of two readings recorded this
colonic nucleic acids (DNA, RNA) and total protein
decreases, p = 0.01
Nucleic acids (DNA and RNA) and TP levels in colon tissues were significantly (P <0.01) inhibited in AA administered group compared to control animals.
PMID:24507431 · both readings recorded this
colonic PGE2 and nitric oxide levels
increases
In addition there was a marked elevation in PGE2 and NO levels in colon tissues of AA administered group when compared to control (P <0.01 and P <0.05, respectively).
PMID:24507431 · one of two readings recorded this
colonic PGE2 and NO
increases
In addition there was a marked elevation in PGE2 and NO levels in colon tissues of AA administered group when compared to control (P <0.01 and P <0.05, respectively).
PMID:24507431 · one of two readings recorded this
colonic pro-inflammatory cytokines (IL-1β, IL-6, TNF-α)
increases
Colonic levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α were significantly (P < 0.05, P < 0.05 and P < 0.01 respectively) increased in AA administered group compared to control rats.
PMID:24507431 · both readings recorded this
colonic SOD and CAT activity
decreases
Activities of the antioxidant enzymes SOD and CAT were significantly (P <0.01 and P <0.05, respectively) inhibited in the colons of AA administered rats compared to control animals.
PMID:24507431 · one of two readings recorded this
colonic SOD and CAT enzyme activity
decreases
Activities of the antioxidant enzymes SOD and CAT were significantly (P <0.01 and P <0.05, respectively) inhibited in the colons of AA administered rats compared to control animals.
PMID:24507431 · one of two readings recorded this
colonic T-GSH and NP-SH (sulfhydryl groups)
decreases
Sulfhydryl's either in form of T-GSH or NP-SH significantly inhibited (P <0.01 and P <0.05, respectively) in colon tissues of AA group of animals.
PMID:24507431 · one of two readings recorded this
colonic TBARS (malondialdehyde) level
increases, p = 0.01
The TBARS levels were found significantly (P < 0.01) increased in AA administered group compared to control rats.
PMID:24507431 · one of two readings recorded this
colonic TBARS (malondialdehyde)
increases, p = 0.01
The TBARS levels were found significantly (P < 0.01) increased in AA administered group compared to control rats.
PMID:24507431 · one of two readings recorded this
colonic TNF-α concentration, ELISA (pg/mg tissue)
increases, p = 0.01
Not recorded as a finding: tnf-alpha node requires serum or plasma concentration; this value is colon tissue
Colonic levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α were significantly (P < 0.05, P < 0.05 and P < 0.01 respectively) increased in AA administered group compared to control rats.
PMID:24507431 · one of two readings recorded this
colonic total and non-protein sulfhydryl groups (T-GSH, NP-SH)
decreases
Sulfhydryl's either in form of T-GSH or NP-SH significantly inhibited (P <0.01 and P <0.05, respectively) in colon tissues of AA group of animals.
PMID:24507431 · one of two readings recorded this
hospital length of stay
increases, PAI mean 2.2 days (range 2-5) vs PEI mean 1.7 days (range 2-3)
Data on the duration of hospital stay were available from one trial for the comparison PEI versus PAI showing a significantly shorter hospital stay for the participants treated with PEI versus PAI.
PMID:25620061 · one of two readings recorded this
adverse events
no effect
There were only mild adverse events in participants treated with either PEI or PAI such as transient fever, flushing, and local pain.
PMID:25620061 · one of two readings recorded this
overall survival, recurrence-free survival, and hospital length of stay after percutaneous acetic acid injection (PAI) for early hepatocellular carcinoma
increases, PAI arm had a longer hospital stay (mean 2.2 days) than the percutaneous ethanol injection (PEI) comparator arm (mean 1.7 days); no trial compared PAI against no intervention
Not recorded as a finding: the comparison was against another active treatment
Data on the duration of hospital stay were available from one trial for the comparison PEI versus PAI showing a significantly shorter hospital stay for the participants treated with PEI versus PAI.
PMID:25620061 · one of two readings recorded this
overall survival
no effect, HR 1.47 (95% CI 0.68-3.19), n = 185
The overall survival (HR 1.47; 95% confidence interval (CI) 0.68 to 3.19) and recurrence-free survival (HR 1.42; 95% CI 0.68 to 2.94) were not statistically significantly different between the intervention groups of the two trials.
PMID:25620061 · one of two readings recorded this
recurrence-free survival
no effect, HR 1.42 (95% CI 0.68-2.94), n = 185
The overall survival (HR 1.47; 95% confidence interval (CI) 0.68 to 3.19) and recurrence-free survival (HR 1.42; 95% CI 0.68 to 2.94) were not statistically significantly different between the intervention groups of the two trials.
PMID:25620061 · one of two readings recorded this
cervical dysplasia prevalence and recurrence in HIV-infected versus HIV-uninfected women
increases, higher among HIV-infected compared with HIV-uninfected women
Dysplasia prevalence and recurrence were higher among HIV-infected compared with HIV-uninfected women but morbidity from treatment was similar.
PMID:25768874 · one of two readings recorded this
dysplasia prevalence and recurrence, HIV-infected versus HIV-uninfected women
increases
Dysplasia prevalence and recurrence were higher among HIV-infected compared with HIV-uninfected women but morbidity from treatment was similar.
PMID:25768874 · one of two readings recorded this
morbidity from cryotherapy or LEEP treatment in HIV-infected versus HIV-uninfected women
no effect, similar between groups
Dysplasia prevalence and recurrence were higher among HIV-infected compared with HIV-uninfected women but morbidity from treatment was similar.
PMID:25768874 · one of two readings recorded this
performance of VIA as a cervical screening test, prevalence of cervical dysplasia, and complications and recurrence rates after cryotherapy or LEEP treatment
Articles reported on performance of VIA, prevalence of cervical dysplasia, and complications and rates of recurrent dysplasia after treatment.
PMID:25768874 · one of two readings recorded this
performance of VIA, prevalence of cervical dysplasia, and complications and rates of recurrent dysplasia after treatment
Articles reported on performance of VIA, prevalence of cervical dysplasia, and complications and rates of recurrent dysplasia after treatment.
PMID:25768874 · one of two readings recorded this
sensitivity for CIN2+
no effect, VIA 84.0% vs VILI 84.2%, p = 0.98, n = 654
For VIA, sensitivity was 84.0% and specificity was 78.6%.
PMID:25849627 · one of two readings recorded this
test positivity rate
no effect, VIA 26.2% vs VILI 30.6%, p = 0.22, n = 654
The test positivity rates were 26.2% for VIA and 30.6% for VILI (p = 0.22).
PMID:25849627 · one of two readings recorded this
time to clearance of Pseudomonas aeruginosa from chronic infected wounds treated with topical 1% acetic acid versus saline dressing
decreases, acetic acid group required on average 7 days less treatment duration to eliminate Pseudomonas than the saline group, n = 32
Not recorded as a finding: this platform holds no node for the endpoint
The duration of treatment required to eliminate the Pseudomonas from the wounds in the acetic acid group was on an average 7 days less than that required by the saline group.
PMID:25851059 · one of two readings recorded this
time to eliminate Pseudomonas aeruginosa from the wound
decreases, acetic acid group averaged 7 days less than saline group; 4.5 days in acetic acid group vs 11.5-15.5 days in saline group, n = 32
The duration of treatment required to eliminate the Pseudomonas from the wounds in the acetic acid group was on an average 7 days less than that required by the saline group.
PMID:25851059 · one of two readings recorded this
sensitivity and specificity for detecting cervical intraepithelial neoplasia grade 2 or 3
VIA sensitivity 73.2% (95%CI 66.5-80.0%), specificity 86.7% (95%CI 82.9-90.4%); VILI sensitivity 88.1% (95%CI 81.5-94.7%), specificity 85.9% (95%CI 81.7-90.0%)
The summary sensitivity and specificity of VIA for CIN2+ were 73.2% (95%CI: 66.5-80.0%) and 86.7% (95%CI: 82.9-90.4%), respectively, and those for VILI were 88.1% (95%CI: 81.5-94.7%) and 85.9% (95%CI: 81.7-90.0%), respectively.
PMID:26014371 · one of two readings recorded this
microbial adaptive tolerance to acetic acid toxicity (growth inhibition via intracellular acidification)
This toxic effect results mostly from acetic acid dissociation inside microbial cells, causing a decrease of intracellular pH and metabolic disturbance by the anion, among other deleterious effects.
PMID:26142387 · one of two readings recorded this
sensitivity and specificity of combined VIA and cervical cytology testing
pooled sensitivity 0.87 (95% CI 0.83-0.90) either-positive case, 0.38 (95% CI 0.29-0.48) both-positive case; specificity 0.79 (95% CI 0.63-0.89) either-positive, 0.98 (95% CI 0.96-0.99) both-positive
Pooled estimates of the sensitivities of the combined tests in either-positive and both-positive cases were 0.87 (95% CI: 0.83-0.90) and 0.38 (95% CI: 0.29-0.48), respectively.
PMID:26320468 · one of two readings recorded this
diagnostic accuracy for specialized intestinal metaplasia
pooled sensitivity 0.96 (95% CI 0.83-0.99), specificity 0.69 (95% CI 0.54-0.81), n = 516
For the characterization of SIM, the pooled sensitivity, specificity, LR+, and LR- for all the included studies (8 studies, 516 patients) were 0.96 (95% CI, 0.83-0.99), 0.69 (95% CI, 0.54-0.81), 3.0 (95% CI, 2.0-4.7), and 0.06 (95% CI, 0.01-0.26), respectively.
PMID:26371851 · one of two readings recorded this
overtreatment rate comparing screening tests for cervical intraepithelial neoplasia
58 more women overtreated per 1000 with VIA versus cervical smear
The greatest difference in overtreatment occurred with VIA instead of the cervical smear (58 more per 1000 women).
PMID:26851054 · one of two readings recorded this
FAA metabolite formation (6-OH-FAA, glucuronides, epoxide-GSH/NAC adducts) in mouse microsomes and in vivo
FAA was metabolized in mice.
PMID:27466491 · one of two readings recorded this
metabolite formation (6-OH-FAA, glucuronides, epoxide adducts)
FAA was metabolized in mice.
PMID:27466491 · one of two readings recorded this
acetic acid tolerance and ethanol productivity loss in Saccharomyces cerevisiae under acetic acid stress
It causes energy depletion, inhibition of metabolic enzyme activity, growth arrest and ethanol productivity losses in Saccharomyces cerevisiae.
PMID:28405910 · one of two readings recorded this
sensitivity and specificity for detecting cervical intraepithelial neoplasia grade 2+
VILI relative sensitivity 1.11 (95% CI 1.06-1.16); relative specificity 0.98 (95% CI 0.95-1.01) versus VIA, n = 101273
VILI was more sensitive, but not less specific, compared with VIA (relative sensitivity = 1.11; 95% confidence interval, 95% CI, 1.06-1.16; relative specificity = 0.98; 95% CI 0.95-1.01).
PMID:28603909 · one of two readings recorded this
sensitivity and specificity of visual inspection with acetic acid (VIA) for detecting CIN Grade 2+ cervical lesions
VIA sensitivity ranged from 16.6% to 82.6%, and specificity 82.1% to 96.8%
Not recorded as a finding: the compound was a reagent, not an exposure
Of the studies that reported test accuracy at CIN Grade 2+, the VIA sensitivity ranged from 16.6% to 82.6%, and specificity 82.1% to 96.8%.
PMID:28704717 · one of two readings recorded this
occurrence and functional role of AAB in natural food fermentation ecosystems
This review summarizes the most recent findings on the occurrence and functional role of AAB in natural food fermentation processes such as lambic beer, water kefir, kombucha, and cocoa.
PMID:28863341 · one of two readings recorded this
molecular architecture and function of PQQ-dependent dehydrogenases (quinoproteins) in AAB
Here, we have provided an overview on the function and molecular architecture of AAB quinoproteins, which can be categorized into six groups according to the primary amino acid sequences.
PMID:30218379 · one of two readings recorded this
food rejection behavior (gustatory)
increases
Here, using the fly, Drosophila melanogaster, we reveal that a member of the ionotropic receptor family, IR7a, is essential for rejecting foods laced with high levels of acetic acid.
PMID:30726729 · one of two readings recorded this
gustatory rejection of food laced with acetic acid, behavioral feeding assay
decreases
Here, using the fly, Drosophila melanogaster, we reveal that a member of the ionotropic receptor family, IR7a, is essential for rejecting foods laced with high levels of acetic acid.
PMID:30726729 · one of two readings recorded this
acute and chronic blood glucose/glycemic response to vinegar intake with meals
decreases, daily vinegar intake of ~10-30 mL improves glycemic response to carbohydrate-rich meals
There is considerable support for vinegar having a positive acute effect on blood glucose levels when combined with carbohydrate-rich meals.
PMID:31221273 · one of two readings recorded this
bacteriocin production, yield and activity in the presence of acetic acid
It was found that acetic acid in the undissociated state can diffuse freely through the hydrophobic layer of the membrane and dissociate, affecting the production, yield, and activity of bacteriocin.
PMID:31336430 · one of two readings recorded this
aryl hydrocarbon receptor (AhR) mRNA expression
no effect, n = 31
Furthermore, there was no significant difference in IAA plasma levels or in AhR mRNA expression in both groups after the 4-week intervention.
PMID:32459282 · one of two readings recorded this
correlation between plasma IAA and AhR mRNA expression at baseline
increases, r=0.48, p = 0.03
Nevertheless, a positive correlation (r=0.48; p=0.03) was observed between IAA plasma levels and AhR mRNA expression at baseline (patients included in both groups).
PMID:32459282 · one of two readings recorded this
plasma indole-3-acetic acid (IAA) concentration
no effect, n = 31
Furthermore, there was no significant difference in IAA plasma levels or in AhR mRNA expression in both groups after the 4-week intervention.
PMID:32459282 · one of two readings recorded this
bacterial degradation/assimilation of indole-3-acetic acid via iac (aerobic) and iaa (anaerobic) gene clusters
One (iac) is responsible for the aerobic degradation of IAA into catechol, and another (iaa) for the anaerobic conversion of IAA to 2-aminobenzoyl-CoA.
PMID:33037916 · one of two readings recorded this
diagnostic accuracy (SROC AUC) for liver fibrosis staging at thresholds F1+, F2+, F3+, F4
AUC 0.8669, 0.8399, 0.8481, and 0.8858 for F1+, F2+, F3+, and F4 respectively, n = 1599
The areas under the SROC curve for the detection of F1 or greater, F2 or greater, F3 or greater, or F4 liver fibrosis were 0.8669, 0.8399, 0.8481, and 0.8858, respectively.
PMID:33256584 · one of two readings recorded this
fasting blood glucose (FBG)
decreases, MD = -35.73 mg/dL [-63.79, -7.67], P = .01, p = 0.01
Additionally, acetic acid supplementation significantly reduced FBG levels (MD = -35.73 mg/dL [-63.79, -7.67], P = .01) in subjects with type 2 diabetes compared with placebo and low-dose comparators.
PMID:33436350 · one of two readings recorded this
HbA1c, HDL cholesterol, and anthropometric markers (body mass index, body fat percentage)
no effect
No significant effects of dietary acetic acid consumption were seen on HbA1c, HDL, or anthropometric markers.
PMID:33436350 · one of two readings recorded this
TORC1 kinase activity
decreases
Our biochemical analyses further demonstrate that IAA inhibits TORC1 both in vivo and in vitro.
PMID:33690632 · one of two readings recorded this
TORC1 (target of rapamycin complex 1) activity / yeast growth inhibition
decreases
Our biochemical analyses further demonstrate that IAA inhibits TORC1 both in vivo and in vitro.
PMID:33690632 · one of two readings recorded this
TORC1 (target of rapamycin complex 1) inhibition by indole-3-acetic acid (IAA), biochemical assays in yeast in vivo and in vitro
decreases
Not recorded as a finding: the trial gave a chemically different species
Our biochemical analyses further demonstrate that IAA inhibits TORC1 both in vivo and in vitro.
PMID:33690632 · one of two readings recorded this
drought-responsive gene expression in rice shoot and root-to-shoot jasmonate signaling induction following root application of acetic acid
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Expression of drought-responsive genes in shoot under subsequent drought conditions was attenuated by acetic acid treatment.
PMID:33737547 · one of two readings recorded this
drought-responsive gene expression in shoot
decreases
Expression of drought-responsive genes in shoot under subsequent drought conditions was attenuated by acetic acid treatment.
PMID:33737547 · one of two readings recorded this
drought-responsive gene expression in shoot
decreases
Expression of drought-responsive genes in shoot under subsequent drought conditions was attenuated by acetic acid treatment.
PMID:33737547 · one of two readings recorded this
root-to-shoot jasmonate signaling and drought-responsive gene expression induced by exogenous acetic acid application to rice roots
increases
Not recorded as a finding: this platform holds no node for the endpoint
In this study, we show that rice rapidly induces jasmonate signaling upon application of acetic acid, resulting in physiological changes similar to those seen under drought.
PMID:33737547 · one of two readings recorded this
root-to-shoot jasmonate signaling induction
increases
In this study, we show that rice rapidly induces jasmonate signaling upon application of acetic acid, resulting in physiological changes similar to those seen under drought.
PMID:33737547 · one of two readings recorded this
root-to-shoot jasmonate signaling
increases
In this study, we show that rice rapidly induces jasmonate signaling upon application of acetic acid, resulting in physiological changes similar to those seen under drought.
PMID:33737547 · one of two readings recorded this
yeast growth/viability and regulated cell death under acetic acid stress
Acetic acid stress represents a frequent challenge to counteract for yeast cells under several environmental conditions and industrial bioprocesses.
PMID:34000094 · one of two readings recorded this
skin disease treatment outcomes with vinegar use (wound care, antimicrobial/antifungal effect, pruritus, head lice, striae gravidarum) and adverse skin effects from misuse
Vinegar possesses antimicrobial and antioxidant properties that provide utility in wound care as well as bacterial and fungal infections.
PMID:34350993 · one of two readings recorded this
presence of temperate bacteriophage particles
Transmission electron microscopy analysis revealed phage-like particles in 15 out of a total 177 acetic acid bacterial strains, all of which showed morphology similar to myoviridae-type phage.
PMID:34732777 · one of two readings recorded this
temperate phage presence in acetic acid bacterial strains, transmission electron microscopy and genome sequencing
phage-like particles in 15 of 177 strains, n = 177
Transmission electron microscopy analysis revealed phage-like particles in 15 out of a total 177 acetic acid bacterial strains, all of which showed morphology similar to myoviridae-type phage.
PMID:34732777 · one of two readings recorded this
cofactor regeneration and electron transport chain function of AAB dehydrogenases in industrial biotransformation
Acetic acid bacteria (AAB) are a group of bacteria that can oxidize many substrates such as alcohols and sugar alcohols and play important roles in industrial biotechnology.
PMID:34793881 · one of two readings recorded this
sensitivity of S-VIA for CIN2+
74.56% (95% CI, 70.16-78.95), n = 426
For the diagnosis of CIN 2+, the sensitivity was 74.56% (95% CI, 70.16 to 78.95; I2 61.30%) and the specificity was 61.75% (95% CI, 56.35 to 67.15; I2 61.75%).
PMID:34936374 · one of two readings recorded this
all-cause mortality
decreases, 0.91 (0.85-0.97), n = 2
For the all-cause mortality, pooled incident rate-ratio was 0.91 (95% CI: 0.85 – 0.97, p-value<0.01, n = 2) (Table 2,.
PMID:35225450 · one of two readings recorded this
cervical cancer mortality
decreases, 0.68 (95% CI: 0.56-0.81), n = 3
Pooled incident rate-ratio of cervical cancer mortality was 0.68 (95% CI: 0.56 – 0.81, p-value <0.01, n = 3).
PMID:35225450 · one of two readings recorded this
invasive cervical cancer incidence
no effect, 0.94 (95% CI: 0.67-1.30), n = 3
Pooled incident rate-ratio of invasive cervical cancer was 0.94 (95% CI: 0.67 – 1.30, p-value=0.69, n = 3) with a 95% prediction interval of 0.392 – 2.392.
PMID:35225450 · one of two readings recorded this
chronic wound healing progression to granulation tissue with topical acetic acid 0.25% gauze dressing, clinical wound observation, case series (n=2)
increases, n = 2
Not recorded as a finding: this platform holds no node for the endpoint
In both cases, the wound progressed to blue-green drainage and wet yellow slough tissue to near-complete beefy granulation tissue.
PMID:35255076 · one of two readings recorded this
chronic wound healing progression to granulation tissue
increases, n = 2
In both cases, the wound progressed to blue-green drainage and wet yellow slough tissue to near-complete beefy granulation tissue.
PMID:35255076 · one of two readings recorded this
wound appearance/drainage and granulation tissue progression
increases, n = 2
In both cases, the wound progressed to blue-green drainage and wet yellow slough tissue to near-complete beefy granulation tissue.
PMID:35255076 · one of two readings recorded this
Bax mitochondrial translocation and cytochrome c release
increases
This was associated with Bax mitochondrial translocation and cyt c release, closely resembling the natural Bax function in the cellular context.
PMID:35362903 · one of two readings recorded this
cell death in yeast expressing human Bax
increases
Here, we found that cell death could be triggered in yeast cells heterologoulsy expressing Bax α with concentrations of acetic acid that are not lethal to wild type cells.
PMID:35362903 · one of two readings recorded this
yeast cell death (Bax-dependent), viability assay
increases
Here, we found that cell death could be triggered in yeast cells heterologoulsy expressing Bax α with concentrations of acetic acid that are not lethal to wild type cells.
PMID:35362903 · one of two readings recorded this
differential protein expression (glycolysis/gluconeogenesis, pyruvate metabolism, sugar phosphotransferase system)
decreases
Proteomics analysis evidenced that differentially expressed proteins involved in the glycolysis and gluconeogenesis pathway, pyruvate metabolism, and sugar phosphotransferase system were all downregulated.
PMID:36125361 · one of two readings recorded this
differential protein expression under acetic acid stress (glycolysis/gluconeogenesis, pyruvate metabolism, sugar phosphotransferase system pathways)
decreases
Proteomics analysis evidenced that differentially expressed proteins involved in the glycolysis and gluconeogenesis pathway, pyruvate metabolism, and sugar phosphotransferase system were all downregulated.
PMID:36125361 · one of two readings recorded this
fatty acid saturation and antioxidant enzyme levels
increases
Meanwhile, saturation of fatty acids and antioxidant enzymes was strengthened.
PMID:36125361 · one of two readings recorded this
fatty acid saturation and antioxidant enzyme levels
increases
Meanwhile, saturation of fatty acids and antioxidant enzymes was strengthened.
PMID:36125361 · one of two readings recorded this
proteomic stress response of Pediococcus acidilactici to acetic acid (glycolysis/gluconeogenesis, pyruvate metabolism, fatty acid metabolism and antioxidant enzyme protein expression), quantitative proteomics
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Proteomics analysis evidenced that differentially expressed proteins involved in the glycolysis and gluconeogenesis pathway, pyruvate metabolism, and sugar phosphotransferase system were all downregulated.
PMID:36125361 · one of two readings recorded this
recurrence rate 8 weeks after treatment completion
10 per cent recurrence rate
There was a 10 per cent recurrence rate 8 weeks after treatment completion.
PMID:36682381 · one of two readings recorded this
treatment success rate for granular myringitis after 2 weeks of topical acetic acid solution, and recurrence rate 8 weeks after treatment completion
no effect, n = 47
Not recorded as a finding: the comparison was against another active treatment
After two weeks, the groups' treatment success rates did not differ significantly.
PMID:36682381 · one of two readings recorded this
treatment success rate for granular myringitis
no effect, n = 47
After two weeks, the groups' treatment success rates did not differ significantly.
PMID:36682381 · one of two readings recorded this
clinical improvement in olfactory function (Sniffin' Sticks test)
increases, 88% improved with EDTA plus training vs 60% with training only, n = 50
Eighty-eight percent of the patients treated with olfactory training in addition to EDTA exhibited clinical improvement, while 60% showed improvement in patients treated with olfactory training only.
PMID:37786364 · one of two readings recorded this
nasal secretion calcium level
decreases
Furthermore, a significant decrease in the measured calcium level in the nasal secretions was demonstrated after the use of ethylene diamine tetra compared to patients treated with olfactory training only.
PMID:37786364 · one of two readings recorded this
embryonic developmental ability of porcine oocytes after in vitro maturation with acetic acid, parthenogenetic-activation embryo development rate
increases
Not recorded as a finding: this platform holds no node for the endpoint
Supplementation of the in vitro maturation medium with acetic acid (1 mmol/L) improved embryonic development.
PMID:38781862 · one of two readings recorded this
embryonic developmental rate after parthenogenetic activation
increases
Supplementation of the in vitro maturation medium with acetic acid (1 mmol/L) improved embryonic development.
PMID:38781862 · both readings recorded this
oocyte ATP and lipid content, mitochondrial membrane potential, reactive oxygen species levels
decreases
Oocytes matured with acetic acid had low adenosine triphosphate and lipid contents, mitochondrial membrane potential and reactive oxygen species levels.
PMID:38781862 · both readings recorded this
phospho-AMPK, phospho-ACC, sirtuin 1, fatty acid synthase, acetyl-coenzyme A synthetase 1 protein levels
increases
Immunostaining revealed that acetic acid increased the levels of phospho-adenosine monophosphate-activated protein kinase, phospho-acetyl-coenzyme A carboxylase, and sirtuin 1 and decreased those of fatty acid synthase and acetyl-coenzyme A synthetase 1.
PMID:38781862 · one of two readings recorded this
VIA positivity in cervical screening (pooled prevalence)
11.93 (95%CI: 11.48-12.37), n = 21066
The overall pooled effect estimate of VIA positivity in Africa was 11.93 with 95% confidence interval of 11.48 to 12.37.
PMID:38957338 · one of two readings recorded this
odds of detecting CIN2+ by HIV status
increases, odds ratio 5.1 (95% CI 1.2-22.5), p = 0.03
The odds of detecting CIN2+ in women who were HIV positive were 5.1 times higher (95% CI 1.2 to 22.5) than in those who were HIV negative (p=0.03).
PMID:39362749 · one of two readings recorded this
sensitivity of VIA for CIN2+
no effect, VIA 25.0% vs VIA+iodine 50.0%, p = 0.5
Sensitivity and specificity done per protocol for VIA was 25.0% (1/4) (95% CI 0.6 to 80.6) and 82.7% (43/52) (95% CI 69.7 to 91.8), respectively.
PMID:39362749 · one of two readings recorded this
antifungal efficacy of acetic acid, alone and combined with chitosan, against Aspergillus flavus mycelial growth and aflatoxin production, minimum inhibitory concentration assay
decreases, AcA MIC: 0.31 %
Not recorded as a finding: this platform holds no node for the endpoint
Results showed that CS/extra AcA strongly inhibited the mycelial growth and aflatoxins production of A. flavus at lower concentrations than CS (MIC > 16.0 mg/mL) or AcA (MIC: 0.31 %).
PMID:39396599 · one of two readings recorded this
Aspergillus flavus mycelial growth and aflatoxin production
decreases, MIC: 0.31 % (AcA alone); MIC > 16.0 mg/mL (CS alone)
Results showed that CS/extra AcA strongly inhibited the mycelial growth and aflatoxins production of A. flavus at lower concentrations than CS (MIC > 16.0 mg/mL) or AcA (MIC: 0.31 %).
PMID:39396599 · one of two readings recorded this
fungal infection and aflatoxin B1 production in peanut kernels
decreases
Moreover, pathogenicity test in peanut kernels showed that 8.0/0.16 CS (mg/mL)/extra AcA (%) could effectively inhibit the fungal infection and aflatoxin B1 production.
PMID:39396599 · one of two readings recorded this
fungal pathogenicity and aflatoxin B1 production in peanut kernels
decreases
Moreover, pathogenicity test in peanut kernels showed that 8.0/0.16 CS (mg/mL)/extra AcA (%) could effectively inhibit the fungal infection and aflatoxin B1 production.
PMID:39396599 · one of two readings recorded this
mycelial growth and aflatoxin production of Aspergillus flavus, minimum inhibitory concentration assay
decreases, AcA MIC 0.31%; CS/extra AcA effective at lower concentrations than CS or AcA alone
Results showed that CS/extra AcA strongly inhibited the mycelial growth and aflatoxins production of A. flavus at lower concentrations than CS (MIC > 16.0 mg/mL) or AcA (MIC: 0.31 %).
PMID:39396599 · one of two readings recorded this
mycelial growth inhibition and aflatoxin B1 production inhibition in Aspergillus flavus by acetic acid, chitosan, and their combination, minimum inhibitory concentration assay
decreases, MIC: 0.31 %
Not recorded as a finding: this platform holds no node for the endpoint
Results showed that CS/extra AcA strongly inhibited the mycelial growth and aflatoxins production of A. flavus at lower concentrations than CS (MIC > 16.0 mg/mL) or AcA (MIC: 0.31 %).
PMID:39396599 · one of two readings recorded this
calcaneal spur width and length, pain intensity, pain pressure threshold, and foot function (FAAM activities of daily living subscale)
increases, mean differences (95% CI): -1.11 mm (-1.46, -0.77) spur width; -1.34 mm (-1.67, -1.01) spur length; -20.71 mm (-24.66, -16.77) pain; 1.45 kg/cm2 (1.05, 1.85) pain pressure threshold; 12.16 points (9.24, 15.09) function, favouring Group A, n = 147
Between-group differences were observed for calcaneal spur width and length, pain intensity, pain pressure threshold and function after 3 weeks favouring Group A (p < 0.001).
PMID:39704113 · one of two readings recorded this
calcaneal spur width and length, pain intensity, pain pressure threshold, and foot function on the FAAM activities of daily living subscale after acetic acid shockwave phonophoresis
increases, mean differences (95% CI): -1.11 mm (-1.46, -0.77) spur width; -1.34 mm (-1.67, -1.01) spur length; -20.71 mm (-24.66, -16.77) pain; 1.45 kg/cm2 (1.05, 1.85) pain pressure threshold; 12.16 points (9.24, 15.09) function, all favouring Group A, n = 147
Not recorded as a finding: this platform holds no node for the endpoint
Between-group differences were observed for calcaneal spur width and length, pain intensity, pain pressure threshold and function after 3 weeks favouring Group A (p < 0.001).
PMID:39704113 · one of two readings recorded this
adverse events / complications
no effect
No adverse effects, including allergic reactions, were observed in the AIM group.
PMID:40079452 · one of two readings recorded this
colonic damage (stool score, colonic wet weight, ulcer score) following intracolonic acetic acid instillation used to induce a rat ulcerative colitis model
increases
Not recorded as a finding: the compound was a reagent, not an exposure
UC induction caused colonic damage, with increases in stool score, colonic wet weight, and ulcer score.
PMID:40845959 · one of two readings recorded this
colonic damage (stool score, colonic wet weight, ulcer score)
increases
UC induction caused colonic damage, with increases in stool score, colonic wet weight, and ulcer score.
PMID:40845959 · one of two readings recorded this
pro-inflammatory cytokine expression and PI3K/Akt pathway activation
decreases
PDRN treatment suppressed the expression of pro-inflammatory cytokines and factors related to the PI3K/Akt pathway, while increasing the expression of cAMP and VEGF.
PMID:40845959 · one of two readings recorded this
stool score, colonic wet weight, ulcer score
decreases
PDRN treatment alleviated histological damage and colonic conditions.
PMID:40845959 · one of two readings recorded this
foam cell cholesterol levels
decreases
Moreover, we found that HI-L. rB16 could reduce foam cell cholesterol levels through the Liver X receptor alpha (LXRα) signaling pathway and regulate hepatic lipid metabolism balance by regulating the expression of key lipid proteins.
PMID:41107841 · one of two readings recorded this
hepatic and serum lipid profile / foam cell cholesterol content in HFD-induced hyperlipidemic mice
decreases
HI-L. rB16 alleviates HFD-induced hyperlipidemia in mice by reducing cholesterol through acetate-mediated LXRα signaling, demonstrating its therapeutic potential as a probiotic for lipid metabolism disorders.
PMID:41107841 · one of two readings recorded this
bacterial biosynthesis pathways and expression level of indole-3-acetic acid (IAA) and its role in plant growth stimulation
Several different IAA biosynthesis pathways are used by these bacteria, with a single bacterial strain sometimes containing more than one pathway.
PMID:8868227 · one of two readings recorded this
Other names
20 names
Resolves to: acetic acid
- Also called
- 10.Methanecarboxylic acidacetateAcOHC2:0CH3-COOHCH3‒COOHCH3CO2HE 260E-260E260Ethanoic acidethoic acidEthylic acidFA 2:0HOAcINS No. 260MeCO2HMeCOOHMethanecarboxylic acidVinegar acid